• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Sage Therapeutics Inc

+ Add to Watchlist

SG7:GR

19.746 EUR 0.299 1.49%

As of 03:01:25 ET on 07/25/2014.

Snapshot for Sage Therapeutics Inc (SG7)

Open: 20.100 Day's Range: 19.746 - 20.100 Volume: 0
Previous Close: 20.045 52wk Range: 19.746 - 21.965 1-Yr Rtn: -

Stock Chart for SG7

No chart data available.
  • SG7:GR 19.746
  • 1D
  • 1M
  • 1Y
20.045
Interactive SG7 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SG7

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 507.71
Shares Outstanding (M) 25.71
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SG7

No data available

Company Profile & Key Executives for SG7

Sage Therapeutics Inc. develops treatments for central nervous system disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Sage Therapeutics operates in the United States.

Jeffrey M Jonas "Jeff"President/CEOKimi IguchiChief Financial Officer
Stephen J KanesChief Medical OfficerAlbert J RobichaudChief Scientific Officer
More Company Profile & Key Executives for SG7

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • SG7 News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil